United States Influenza Vaccines Market Report 2017

United States Influenza Vaccines Market Report 2017

1 Influenza Vaccines Overview

1.1 Product Overview and Scope of Influenza Vaccines

1.2 Classification of Influenza Vaccines by Product Category

1.2.1 United States Influenza Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Influenza Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Trivalent Influenza Vaccines

1.2.4 Quadrivalent Vaccines

1.3 United States Influenza Vaccines Market by Application/End Users

1.3.1 United States Influenza Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 United States Influenza Vaccines Market by Region

1.4.1 United States Influenza Vaccines Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Influenza Vaccines Status and Prospect (2012-2022)

1.4.3 Southwest Influenza Vaccines Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Influenza Vaccines Status and Prospect (2012-2022)

1.4.5 New England Influenza Vaccines Status and Prospect (2012-2022)

1.4.6 The South Influenza Vaccines Status and Prospect (2012-2022)

1.4.7 The Midwest Influenza Vaccines Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Influenza Vaccines (2012-2022)

1.5.1 United States Influenza Vaccines Sales and Growth Rate (2012-2022)

1.5.2 United States Influenza Vaccines Revenue and Growth Rate (2012-2022)

2 United States Influenza Vaccines Market Competition by Players/Suppliers

2.1 United States Influenza Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Influenza Vaccines Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Influenza Vaccines Average Price by Players/Suppliers (2012-2017)

2.4 United States Influenza Vaccines Market Competitive Situation and Trends

2.4.1 United States Influenza Vaccines Market Concentration Rate

2.4.2 United States Influenza Vaccines Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Influenza Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Influenza Vaccines Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Influenza Vaccines Sales and Market Share by Region (2012-2017)

3.2 United States Influenza Vaccines Revenue and Market Share by Region (2012-2017)

3.3 United States Influenza Vaccines Price by Region (2012-2017)

4 United States Influenza Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Influenza Vaccines Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Influenza Vaccines Revenue and Market Share by Type (2012-2017)

4.3 United States Influenza Vaccines Price by Type (2012-2017)

4.4 United States Influenza Vaccines Sales Growth Rate by Type (2012-2017)

5 United States Influenza Vaccines Sales (Volume) by Application (2012-2017)

5.1 United States Influenza Vaccines Sales and Market Share by Application (2012-2017)

5.2 United States Influenza Vaccines Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Influenza Vaccines Players/Suppliers Profiles and Sales Data

6.1 Sanofi Pasteur

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Influenza Vaccines Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Sanofi Pasteur Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 GSK

6.2.2 Influenza Vaccines Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 GSK Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Seqirus

6.3.2 Influenza Vaccines Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Seqirus Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 AstraZeneca

6.4.2 Influenza Vaccines Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 AstraZeneca Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Protein Science Corporation

6.5.2 Influenza Vaccines Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Protein Science Corporation Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

...

7 Influenza Vaccines Manufacturing Cost Analysis

7.1 Influenza Vaccines Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Influenza Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Influenza Vaccines Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Influenza Vaccines Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Influenza Vaccines Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Influenza Vaccines Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Influenza Vaccines Sales Volume Forecast by Type (2017-2022)

11.3 United States Influenza Vaccines Sales Volume Forecast by Application (2017-2022)

11.4 United States Influenza Vaccines Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Influenza Vaccines

Figure United States Influenza Vaccines Market Size (K Units) by Type (2012-2022)

Figure United States Influenza Vaccines Sales Volume Market Share by Type (Product Category) in 2016

Figure Trivalent Influenza Vaccines Product Picture

Figure Quadrivalent Vaccines Product Picture

Figure United States Influenza Vaccines Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Influenza Vaccines by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Other Examples

Table Key Downstream Customer in Other

Figure United States Influenza Vaccines Market Size (Million USD) by Region (2012-2022)

Figure The West Influenza Vaccines Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Influenza Vaccines Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Influenza Vaccines Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Influenza Vaccines Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Influenza Vaccines Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Influenza Vaccines Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Influenza Vaccines Sales (K Units) and Growth Rate (2012-2022)

Figure United States Influenza Vaccines Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Influenza Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Influenza Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Influenza Vaccines Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Influenza Vaccines Sales Share by Players/Suppliers

Figure 2017 United States Influenza Vaccines Sales Share by Players/Suppliers

Figure United States Influenza Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Influenza Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Influenza Vaccines Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Influenza Vaccines Revenue Share by Players/Suppliers

Figure 2017 United States Influenza Vaccines Revenue Share by Players/Suppliers

Table United States Market Influenza Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Influenza Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Influenza Vaccines Market Share of Top 3 Players/Suppliers

Figure United States Influenza Vaccines Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Influenza Vaccines Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Influenza Vaccines Product Category

Table United States Influenza Vaccines Sales (K Units) by Region (2012-2017)

Table United States Influenza Vaccines Sales Share by Region (2012-2017)

Figure United States Influenza Vaccines Sales Share by Region (2012-2017)

Figure United States Influenza Vaccines Sales Market Share by Region in 2016

Table United States Influenza Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Influenza Vaccines Revenue Share by Region (2012-2017)

Figure United States Influenza Vaccines Revenue Market Share by Region (2012-2017)

Figure United States Influenza Vaccines Revenue Market Share by Region in 2016

Table United States Influenza Vaccines Price (USD/Unit) by Region (2012-2017)

Table United States Influenza Vaccines Sales (K Units) by Type (2012-2017)

Table United States Influenza Vaccines Sales Share by Type (2012-2017)

Figure United States Influenza Vaccines Sales Share by Type (2012-2017)

Figure United States Influenza Vaccines Sales Market Share by Type in 2016

Table United States Influenza Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Influenza Vaccines Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Influenza Vaccines by Type (2012-2017)

Figure Revenue Market Share of Influenza Vaccines by Type in 2016

Table United States Influenza Vaccines Price (USD/Unit) by Types (2012-2017)

Figure United States Influenza Vaccines Sales Growth Rate by Type (2012-2017)

Table United States Influenza Vaccines Sales (K Units) by Application (2012-2017)

Table United States Influenza Vaccines Sales Market Share by Application (2012-2017)

Figure United States Influenza Vaccines Sales Market Share by Application (2012-2017)

Figure United States Influenza Vaccines Sales Market Share by Application in 2016

Table United States Influenza Vaccines Sales Growth Rate by Application (2012-2017)

Figure United States Influenza Vaccines Sales Growth Rate by Application (2012-2017)

Table Sanofi Pasteur Basic Information List

Table Sanofi Pasteur Influenza Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Sanofi Pasteur Influenza Vaccines Sales Growth Rate (2012-2017)

Figure Sanofi Pasteur Influenza Vaccines Sales Market Share in United States (2012-2017)

Figure Sanofi Pasteur Influenza Vaccines Revenue Market Share in United States (2012-2017)

Table GSK Basic Information List

Table GSK Influenza Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure GSK Influenza Vaccines Sales Growth Rate (2012-2017)

Figure GSK Influenza Vaccines Sales Market Share in United States (2012-2017)

Figure GSK Influenza Vaccines Revenue Market Share in United States (2012-2017)

Table Seqirus Basic Information List

Table Seqirus Influenza Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Seqirus Influenza Vaccines Sales Growth Rate (2012-2017)

Figure Seqirus Influenza Vaccines Sales Market Share in United States (2012-2017)

Figure Seqirus Influenza Vaccines Revenue Market Share in United States (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Influenza Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure AstraZeneca Influenza Vaccines Sales Growth Rate (2012-2017)

Figure AstraZeneca Influenza Vaccines Sales Market Share in United States (2012-2017)

Figure AstraZeneca Influenza Vaccines Revenue Market Share in United States (2012-2017)

Table Protein Science Corporation Basic Information List

Table Protein Science Corporation Influenza Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Protein Science Corporation Influenza Vaccines Sales Growth Rate (2012-2017)

Figure Protein Science Corporation Influenza Vaccines Sales Market Share in United States (2012-2017)

Figure Protein Science Corporation Influenza Vaccines Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Influenza Vaccines

Figure Manufacturing Process Analysis of Influenza Vaccines

Figure Influenza Vaccines Industrial Chain Analysis

Table Raw Materials Sources of Influenza Vaccines Major Players/Suppliers in 2016

Table Major Buyers of Influenza Vaccines

Table Distributors/Traders List

Figure United States Influenza Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Influenza Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Influenza Vaccines Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Influenza Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Influenza Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Influenza Vaccines Sales Volume (K Units) Forecast by Type in 2022

Table United States Influenza Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Influenza Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Influenza Vaccines Sales Volume (K Units) Forecast by Application in 2022

Table United States Influenza Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Influenza Vaccines Sales Volume Share Forecast by Region (2017-2022)

Figure United States Influenza Vaccines Sales Volume Share Forecast by Region (2017-2022)

Figure United States Influenza Vaccines Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources